LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -4.18%14.46M | 6.91%18.34M | -17.06%14.8M | 56.70%66.34M | 6.96%16.25M | 14.49%15.09M | 123.12%17.16M | 184.48%17.84M | 61.23%42.33M | 82.52%15.2M |
Operating revenue | -4.18%14.46M | 6.91%18.34M | -17.06%14.8M | 56.70%66.34M | 6.96%16.25M | 14.49%15.09M | 123.12%17.16M | 184.48%17.84M | 61.23%42.33M | 82.52%15.2M |
Cost of revenue | -2.90%10.07M | -2.87%12.68M | -24.52%10.49M | 40.54%49.24M | -2.21%11.93M | -7.90%10.37M | 96.30%13.05M | 181.61%13.89M | 71.17%35.03M | 85.52%12.2M |
Gross profit | -6.97%4.39M | 37.97%5.67M | 9.19%4.31M | 134.28%17.1M | 44.21%4.33M | 145.78%4.72M | 294.24%4.11M | 195.07%3.95M | 26.06%7.3M | 71.27%3M |
Operating expense | 11.70%6.6M | 11.47%6.03M | 4.53%6.02M | -0.64%22.51M | -0.97%5.43M | 5.15%5.91M | -11.10%5.41M | 5.38%5.76M | 17.58%22.66M | 0.35%5.49M |
Selling and administrative expenses | 12.43%5.31M | 8.07%4.59M | 4.17%4.73M | 13.57%17.62M | -0.07%4.11M | 21.00%4.72M | 6.25%4.25M | 29.67%4.54M | 23.14%15.52M | 20.19%4.11M |
Research and development costs | 8.80%1.29M | 23.92%1.44M | 5.89%1.3M | -31.52%4.89M | -3.64%1.32M | -31.00%1.18M | -44.35%1.16M | -37.82%1.22M | 7.08%7.14M | -32.86%1.37M |
Operating profit | -85.93%-2.21M | 72.01%-365K | 5.63%-1.71M | 64.77%-5.41M | 55.45%-1.11M | 67.89%-1.19M | 74.16%-1.3M | 56.12%-1.81M | -13.94%-15.36M | 33.07%-2.49M |
Net non-operating interest income expense | -67.83%-433K | -16.62%-449K | -22.87%-403K | -431.35%-1.34M | -121.69%-368K | -396.15%-258K | -1,141.94%-385K | -10,833.33%-328K | 59.49%-252K | -4,050.00%-166K |
Non-operating interest expense | 67.83%433K | 16.62%449K | 22.87%403K | 431.35%1.34M | 121.69%368K | 396.15%258K | 1,141.94%385K | 10,833.33%328K | -59.49%252K | 4,050.00%166K |
Other net income (expense) | 8K | 0 | 8K | |||||||
Other non- operating income (expenses) | ---- | ---- | ---- | --8K | --0 | ---- | --8K | ---- | ---- | ---- |
Income before tax | -82.70%-2.64M | 51.58%-814K | 1.26%-2.11M | 56.81%-6.74M | 44.36%-1.48M | 61.46%-1.45M | 66.89%-1.68M | 48.21%-2.14M | -22.01%-15.61M | 28.68%-2.65M |
Income tax | ||||||||||
Net income | -82.70%-2.64M | 51.58%-814K | 1.26%-2.11M | 56.81%-6.74M | 44.36%-1.48M | 61.46%-1.45M | 66.89%-1.68M | 48.21%-2.14M | -22.01%-15.61M | 28.68%-2.65M |
Net income continuous Operations | -82.70%-2.64M | 51.58%-814K | 1.26%-2.11M | 56.81%-6.74M | 44.36%-1.48M | 61.46%-1.45M | 66.89%-1.68M | 48.21%-2.14M | -22.01%-15.61M | 28.68%-2.65M |
Minority interest income | ||||||||||
Net income attributable to the parent company | -82.70%-2.64M | 51.58%-814K | 1.26%-2.11M | 56.81%-6.74M | 44.36%-1.48M | 61.46%-1.45M | 66.89%-1.68M | 48.21%-2.14M | -22.01%-15.61M | 28.68%-2.65M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -82.70%-2.64M | 51.58%-814K | 1.26%-2.11M | 56.81%-6.74M | 44.36%-1.48M | 61.46%-1.45M | 66.89%-1.68M | 48.21%-2.14M | -22.01%-15.61M | 28.68%-2.65M |
Basic earnings per share | -77.78%-0.16 | 50.00%-0.05 | 0.00%-0.13 | 58.42%-0.42 | 47.06%-0.09 | 60.87%-0.09 | 68.75%-0.1 | 56.67%-0.13 | 6.48%-1.01 | 39.29%-0.17 |
Diluted earnings per share | -77.78%-0.16 | 50.00%-0.05 | 0.00%-0.13 | 58.42%-0.42 | 47.06%-0.09 | 60.87%-0.09 | 68.75%-0.1 | 56.67%-0.13 | 6.48%-1.01 | 39.29%-0.17 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |